Read More Pharma Industry News Why anti-CD20 competition in multiple sclerosis is shifting toward real-world performance data Discover why real-world data is reshaping anti-CD20 competition in MS and what it means for TG Therapeutics, Inc.’s BRIUMVI strategy. Read more. bySoujanya RaviApril 24, 2026